Peter Abdou
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
Papers in
-
- Immunotherapy and Immune Responses 3
- Immune cells in cancer 2
-
- Nanoplatforms for cancer theranostics 3
- Co-authors
- Zhen Gu (7 shared papers)Guojun Chen (5 shared papers)Zejun Wang (5 shared papers)Jinqiang Wang (5 shared papers)Hongjun Li (4 shared papers)Gianpietro Dotti (3 shared papers)Dongquan Shi (1 shared paper)Qing Jiang (1 shared paper)
- Journals
- Advanced Science (1 paper)Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (1 paper)Nature Nanotechnology (1 paper)Regenerative Biomaterials (1 paper)Matter (1 paper)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Peter Abdou
7 papers receiving 718 citations
Peter Abdou's Hit Papers
Peers
Comparison fields: 5 of 68
- Biomaterials 172
- Pharmaceutical Science 71
- Immunology 178
- Molecular Medicine 39
- Biomedical Engineering 325
Countries citing papers authored by Peter Abdou
This map shows the geographic impact of Peter Abdou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Abdou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Abdou more than expected).
Fields of papers citing papers by Peter Abdou
This network shows the impact of papers produced by Peter Abdou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Abdou. The network helps show where Peter Abdou may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Abdou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Bioorthogonal catalytic patch Hit paper breakdown → | 2021 | 219 |
| 2 | 2020 | 156 | |
| 3 | 2019 | 145 | |
| 4 | 2019 | 71 | |
| 5 | 2020 | 60 | |
| 6 | 2019 | 45 | |
| 7 | 2022 | 25 |
About Peter Abdou
Peter Abdou is a scholar working on Immunology, Biomedical Engineering, Oncology, Biotechnology and Organic Chemistry, having authored 7 papers that have together received 721 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Nanoplatforms for cancer theranostics (3 papers), Cancer Research and Treatments (2 papers), Immune cells in cancer (2 papers), Click Chemistry and Applications (1 paper), Electrospun Nanofibers in Biomedical Applications (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper) and Cancer, Stress, Anesthesia, and Immune Response (1 paper). The work is most often cited by research in Biomaterials (172 citations), Pharmaceutical Science (71 citations), Immunology (178 citations), Molecular Medicine (39 citations) and Biomedical Engineering (325 citations). Peter Abdou has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Zhen Gu, Guojun Chen, Zejun Wang, Jinqiang Wang, Hongjun Li, Gianpietro Dotti, Dongquan Shi, Qing Jiang, Jiawei Li and Xingquan Xu. Their work appears in journals such as Advanced Science, Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, Nature Nanotechnology, Regenerative Biomaterials and Matter.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.